impact:

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progr...

According to PR-model, Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progr... is ranked 1,246,058^th in multilingual Wikipedia, in particular this website is ranked 1,014,447^th in English Wikipedia.

#Language

PR-model F-model AR-model

*All Wikipedias

1,246,058^th place

974,024^th place

1,293,170^th place

enEnglish

1,014,447^th place

1,137,797^th place

1,082,156^th place

skSlovak

6,268^th place

5,243^rd place

4,731^st place